Characteristics and outcome of Chinese patients with both antineutrophil cytoplasmic antibody and antiglomerular basement membrane antibodies

Nephron - Clinical Practice

Volumn 107, Issue 2, 2007, Pages

  Zhao, Juan ^b   Yang, Rui ^b   Cui, Zhao ^b   Chen, Min ^b   Zhao, Ming Hui ^a   Wang, Hai Yan ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b NONE

Author keywords

Antiglomerular basement membrane antibody; Antineutrophil cytoplasmic antibody; Double positive prognosis

Indexed keywords

ANTIBODY; ANTIGEN; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA CHAIN NC1 FRAGMENT; CREATININE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMSTATIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN SPECIFICITY; ANURIA; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS; HEMOPTYSIS; HUMAN; KIDNEY DISEASE; LUNG DISEASE; MALE; OLIGURIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROLOGY; SURVIVAL; SYSTEMIC VASCULITIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; CHILD; FEMALE; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; VASCULITIS;

EID: 35048870207     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107803     Document Type: Article

References (21)

1. Chen M, Yu F, Zhang Y, Zhao MH: Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibodies associated systemic vasculitides: a study of 426 patients from a single center. Postgrad Med J 2005;81:723-727.
2. Jayne D, Rasmussen N, Andrassy K, et al: Randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44.
3. O'Donoghue DJ, Short CD, Brenchley PE, Lawler W, Ballardie FW: Sequential development of systemic vasculitis with antineutrophil cytoplasmic antibodies complicating antiglomerular basement membrane disease. Clin Nephrol 1989;32:251-255.
4. Jayne DR, Marshall PD, Jones SJ, Lockwood CM: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990;37:965-970.
5. Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C: Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997;8:376-385.
6. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD: Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004;66:1535-1540.
7. Bosch X, Mirapeix E, Font J, et al: Prognostic implication of antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in antiglomerular basement membrane disease. Clin Nephrol 1991;36:107-113.
8. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW: Coexistence of antiglomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005;46:253-262.
9. Xin G, Zhao MH, Wang HY: Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in Chinese patients with clinically suspected vasculitis. Clin Diagn Lab Immunol 2004;11:559-562.
10. Cui Z, Zhao MH, Xin G, Wang HY: Characteristics and prognosis of Chinese patients with antiglomerular basement membrane disease. Nephron Clin Pract 2005;99:c49-c55.
11. Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY: Antigen and epitope specificity of antiglomerular basement membrane antibodies in patients with Goodpasture's disease with or without antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 2007;18:1338-1343.
12. Yang G, Tang Z, Chen Y, Zeng C, Chen H, Liu Z, Li L: Antineutrophil cytoplasmic antibodies in Chinese patients with anti-GBM crescentic glomerulonephritis. Clin Nephrol 2005;63:423-428.
13. Weber MF, Andrassy K, Pullig O, Koderisch J, Netzer K: Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol 1992;2:1227-1234.
14. Meyers CM, Kalluri R, Neilson EG: Anti-basement membrane antibodies in Good-pasture syndrome; in Neilson EG, Couser WC (eds): Immunologic Renal Diseases, chapt 43. New York, Lippincott-Raven, 1996, pp 959-973.
15. Little MA, Pusey CD: Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol 2004(suppl 8):S10-S19.
16. Arends J, Wu J, Borillo J, Troung L, Zhou C, Vigneswaran N, Lou YH: T-cell epitope mimicry in antiglomerular basement membrane disease. J Immunol 2006;176:1252-1258.
17. Verburgh CA, Bruijn JA, Daha MR, van Es LA: Sequential development of anti-GBM nephritis and ANCA-associated pauci-immune glomerulonephritis. Am J Kidney Dis 1999;34:344-348.
18. Serratrice J, Chiche L, Dussol B, Granel B, Daniel L, Jego-Desplat S, Disdier P, Swiader L, Berland Y, Weiller PJ: Sequential development of perinuclear ANCA-associated vasculitis and antiglomerular basement membrane glomerulonephritis. Am J Kidney Dis 2004;43:e26-e30.
19. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002;110:955-963.
20. Brouwer E, Huitema MG, Klok PA, de Weerd H, Tervaert JW, Weening JJ, Kallenberg CG: Antimyeloperoxidase associated proliferative glomerulonephritis: an animal model. J Exp Med 1993;177:905-914.
21. Phelps RG, Rees AJ: The HLA complex in Goodpasture's disease: A model for analyzing susceptibility to autoimmunity Kidney Int 1999;56:1638-1653.